Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. (Q40014063)
Jump to navigation
Jump to search
scientific article published on 11 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. |
scientific article published on 11 February 2008 |
Statements
1 reference
Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I. (English)
1 reference
Carsten Bokemeyer
1 reference
Artur Gontarewicz
1 reference
Stefan Balabanov
1 reference
Gunhild Keller
1 reference
Riccardo Colombo
1 reference
Alessio Graziano
1 reference
Enrico Pesenti
1 reference
Daniel Benten
1 reference
Walter Fiedler
1 reference
Jürgen Moll
1 reference
Tim H Brümmendorf
1 reference
11 February 2008
1 reference
Identifiers
1 reference